A competitive ELISA for the detection of group-specific antibody to equine encephalosis virus.

The research article focuses on the development and testing of a competitive ELISA (C-ELISA) for the detection of antibodies to the equine encephalosis virus (EEV), highlighting the ELISA’s effectiveness and its potential use in differentiating between EEV and African horse sickness virus.

Development of EEV C-ELISA

• The authors developed a group-specific, competitive ELISA (C-ELISA) based on polyclonal antibodies for the purpose of detecting antibodies to equine encephalosis virus (EEV).
• This assay measured the competition between a specific guinea pig antiserum and a test serum for a pre-titrated EEV antigen.
• The C-ELISA was able to detect antibodies to all seven known EEV serotypes, demonstrating its broad applicability for EEV detection.

Non-cross reactivity with other Arboviruses

• The researchers found that reference antisera raised against other arboviruses didn’t cross-react with EEV antigen. This indicates the specificity of the C-ELISA for EEV detection. This non-cross reactivity is crucial for assuring the accuracy of the derived results.

Establishing Baseline for Negative Population

• Using negative sera (blood serum without EEV antibodies) from horses in the United Kingdom, the authors were able to establish a baseline for a negative population.
• This set a ‘0’ point reference for the assay, allowing for correct differentiation between negative and positive results.

Testing on South African Horses

• The assay was then used to test both negative and positive populations of horses in South Africa, which were selected on the basis of virus neutralization.
• The optimality of the test parameters, where the assay sensitivity and specificity are close to 100%, was calculated using two-graph receiver operator characteristic (TG-ROC) analysis.
• The optimal cut-off value, beyond which the sample is considered as positive, was determined to be at 29.5% inhibition.

Reliability of the EEV C-ELISA

• The results showed the developed EEV C-ELISA to be sensitive, specific, and reliable, making it a valid approach for the detection of EEV, an important pathogen in horses.

Differential Serological Diagnosis

• The authors suggest that the C-ELISA can be used along with other available ELISAs for the African horse sickness virus (AHSV), allowing for a differential serological diagnosis between EEV and AHSV.
• A differential serological diagnosis allows for the identification of the disease based on the detection of specific antibodies in the patient’s serum.